The LinkedIn post and pitch materials heavily leverage his background as a "mission-driven pharmacist." In Maryland, that credential is now legally inactive.
11Three Capital is asking for a $5,000,000 SAFE note to "commercialize a non- patented micelle drug delivery platform" and "launch a Minimum Viable Product (MVP)." To commercialize, formulate, or distribute a pharmaceutical product (even an MVP) in Maryland or ship across state lines, an entity needs active state board permits, FDA compliance, and licensed oversight.
Neither 11Three Capital nor Univec holds active facility permits with the Maryland Board of Pharmacy. Even if a personal license were active, an individual license does not replace a State Board Facility Permit or FDA Registration.
The famous Dalton Product Launch in Maryland may never happen anytime soon...if it ever happens...
PL